LEADER 00997nam2-2200349---450-
001 990003505230203316
005 20110228114913.0
035   $a000350523
035   $aUSA01000350523
035   $a(ALEPH)000350523USA01
035   $a000350523
100   $a20110228d--------km-y0itay50------ba
101   $aita
102   $aIT
105   $a||||||||001yy
200 1 $a<<Gli>> acidi biliari in terapia$erealtà e prospettive$fMauro Podda...[et al.]
210   $aMilano$cs.n.
215   $a36 p.$cill.$d22 cm
225 2 $aGuida ai farmaci$v9
300   $aSuppl. a: Il polso, dicembre 1988, n.12
410  0$1001000350506$12001$aGuida ai farmaci$v9
606 0 $aFarmaci$2BNCF
676   $a615.1
701  1$aPODDA,$bMauro$0609579
801  0$aIT$bsalbc$gISBD
912   $a990003505230203316
951   $aFDC 292/9$b856 Med.$cFDC
959   $aBK
969   $aMED
979   $aMANCUSO$b90$c20110228$lUSA01$h1149
996   $aAcidi biliari in terapia$91114434
997   $aUNISA